CoMentis Inc - logo

CoMentis Inc - Company & Market Research Reports

CoMentis specializes in the development of small-molecule drugs to treat neurovascular diseases with a focus on Alzheimer's disease and schizophrenia. They cover the research and development spectrum from initial drug design through manufacturing and clinical trials. The company, with headquarters in South San Francisco, was formed by the merger of Zapaq, Inc. and Athenagen, Inc. in 2006. It is also working on nicotinic acetylcholine receptor modulators for the treatment of cognitive disorders.


Beta Secretase Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

Beta Secretase Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Cognitive Impairment - Pipeline Review, H1 2015 - Product Thumbnail Image

Cognitive Impairment - Pipeline Review, H1 2015

  • Report
  • 243 Pages
From
Obesity - Pipeline Review, H1 2018 - Product Thumbnail Image

Obesity - Pipeline Review, H1 2018

  • Report
  • 526 Pages
From
Obesity - Pipeline Review, H2 2017 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2017

  • Report
  • 518 Pages
From
Smoking Addiction - Pipeline Review, H2 2017 - Product Thumbnail Image

Smoking Addiction - Pipeline Review, H2 2017

  • Report
  • 89 Pages
From
Smoking Addiction - Pipeline Review, H1 2017 - Product Thumbnail Image

Smoking Addiction - Pipeline Review, H1 2017

  • Report
  • 86 Pages
From
Addiction - Pipeline Review, H2 2015 - Product Thumbnail Image

Addiction - Pipeline Review, H2 2015

  • Report
  • 369 Pages
From
Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030 - Product Thumbnail Image

Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030

  • Report
  • 292 Pages
From
Wet AMD- Pipeline Insight, 2018 - Product Thumbnail Image

Wet AMD- Pipeline Insight, 2018

  • Drug Pipelines
  • 106 Pages
From
Retinal Degeneration - Pipeline Insight, 2018 - Product Thumbnail Image

Retinal Degeneration - Pipeline Insight, 2018

  • Drug Pipelines
  • 217 Pages
From
Competitor Analysis: Wet Age-Related Macular Degeneration (AMD) - Product Thumbnail Image

Competitor Analysis: Wet Age-Related Macular Degeneration (AMD)

  • Report
  • 43 Pages
From
Angiogenesis Inhibitors and Stimulators - Global Business Strategic Report - Product Thumbnail Image

Angiogenesis Inhibitors and Stimulators - Global Business Strategic Report

  • Report
  • 675 Pages
From
Smoking Cessation - Pipeline Review, H2 2015 - Product Thumbnail Image

Smoking Cessation - Pipeline Review, H2 2015

  • Report
  • 110 Pages
From
Endotoxemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Endotoxemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 54 Pages
From
CoMentis, Inc. - Product Pipeline Review - 2015 - Product Thumbnail Image

CoMentis, Inc. - Product Pipeline Review - 2015

  • Company Profile
  • 22 Pages
From
CoMentis, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

CoMentis, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
CoMentis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

CoMentis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 30 Pages
From
  • 17 Results (Page 1 of 1)
Loading Indicator
adroll